India In-Vitro Diagnostics Market: Growth, Challenges, and Opportunities

India In-Vitro Diagnostics Market: Growth, Challenges, and Opportunities

According to Next Move Strategy Consulting, the global India In-Vitro Diagnostics Market is predicted to reach USD 5 billion by 2030, at a CAGR of 7% from 2024 to 2030. The India in-vitro diagnostics (IVD) market is witnessing substantial growth, driven by advancements in diagnostic technologies, increasing healthcare demands, and the rising prevalence of infectious and chronic diseases. IVD refers to tests conducted on samples like bodily fluids, tissues, or cells outside the body to diagnose diseases, monitor therapy, and assess health conditions. These tests, leveraging techniques such as molecular diagnostics, clinical chemistry, and immunoassays, play a critical role in improving healthcare outcomes in India.

Download Free Sample: https://www.nextmsc.com/india-in-vitro-diagnostics-market/request-sample 

Impact of COVID-19 on the Market

The COVID-19 pandemic served as a significant catalyst for the IVD market in India. During the pandemic, the demand for IVD kits surged due to the need for mass testing and early detection of the virus. This demand was met with rapid innovations and the production of diagnostic reagents and kits by domestic and international manufacturers.

For instance, the widespread adoption of real-time PCR kits and rapid antigen tests underscored the importance of IVD in combating public health emergencies. Although the demand for COVID-19-specific diagnostic kits has declined due to increased vaccination rates and lower infection rates, the pandemic has left a lasting impact by highlighting the importance of robust diagnostic infrastructure.

Drivers of Market Growth

Several factors continue to drive the growth of India’s IVD market:

  1. Rising Burden of Chronic Diseases: The increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer has significantly boosted the demand for IVD solutions. According to the World Health Organization (WHO), non-communicable diseases account for 63% of total deaths in India, emphasizing the need for early detection and monitoring through advanced diagnostic tools.
  2. Adoption of Point-of-Care Testing (POCT): The growing acceptance of POCT technologies is transforming healthcare delivery in India. These devices provide rapid results, making them indispensable in emergency care, rural healthcare settings, and primary care centers. POCT applications for glucose monitoring, infectious diseases, and pregnancy testing are gaining traction, improving diagnostic efficiency and patient outcomes.
  3. Increasing Awareness of Personalized Medicine: The awareness and acceptance of personalized medicine are steadily rising in India, facilitated by advances in genomics and molecular diagnostics. Companion diagnostics, which guide targeted therapies, are becoming a vital component of cancer care and other chronic disease management.
  4. Government Initiatives and Healthcare Investments: India's government is playing a pivotal role in fostering the growth of the IVD market. Initiatives such as Ayushman Bharat and Make in India have encouraged investments in healthcare infrastructure and local manufacturing of diagnostic kits, enhancing accessibility and affordability.

Segment Analysis

Reagent Segment

The reagent segment is expected to witness lucrative growth, driven by the increasing use of chemical, biological, and immunological components in IVD processes. The COVID-19 pandemic further accelerated demand for diagnostic reagents, with companies introducing innovative solutions to meet evolving needs.

Inquire Before Buying: https://www.nextmsc.com/india-in-vitro-diagnostics-market/inquire-before-buying 

For example, the launch of specialized diagnostic reagents for detecting variants of the SARS-CoV-2 virus showcased the agility of IVD manufacturers in adapting to new challenges. Such innovations are anticipated to sustain market growth in the coming years.

Cancer Diagnostics

Cancer diagnostics is emerging as one of the fastest-growing segments within the Indian IVD market. The rising incidence of cancers such as breast, lung, and cervical cancer is fueling the demand for advanced diagnostic tools. According to the National Cancer Registry Program, India records over 1.39 million cancer cases annually, with this number projected to rise in the coming decades.

Efforts by healthcare organizations and the government to enhance cancer screening rates are also contributing to this segment’s growth. For instance, initiatives to promote cervical cancer screening among women have increased the adoption of diagnostic kits and equipment.

Challenges in the Market

Despite its potential, the Indian IVD market faces several challenges, including:

  • High Costs of Development and Regulation: Developing IVD products involves substantial financial investments in research, clinical trials, and regulatory compliance. This can deter smaller players and limit innovation in the market.
  • Limited Awareness in Rural Areas: While urban centers are witnessing rapid adoption of IVD technologies, rural areas often face a lack of awareness and access to diagnostic facilities, hindering market penetration.
  • Competitive Landscape: The market is moderately competitive, with key players like Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific dominating the space. Local companies are also emerging as strong contenders, leveraging government support and cost advantages.

Conclusion

The India in-vitro diagnostics market is poised for significant growth, fueled by advancements in diagnostic technologies, the rising prevalence of chronic diseases, and supportive government initiatives. Despite challenges such as high development costs and rural healthcare gaps, the market is set to expand due to increasing awareness, demand for POCT, and innovations in cancer diagnostics.

Also, Browse Related Reports:   

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting: 

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
Back to blog